TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H ( (HK:1541) ) just unveiled an update.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has established a Nomination Committee to improve its corporate governance structure. This committee is responsible for the selection and appointment of directors and senior management, aiming to optimize board composition and enhance decision-making processes.
More about ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative cancer immunotherapy products. The company aims to enhance cancer treatment through its specialized therapies, targeting a significant market in oncology.
Average Trading Volume: 5,194,140
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.61B
Learn more about 1541 stock on TipRanks’ Stock Analysis page.